Nicaragua

1.

Global Fund Board approves $36 million for country and multicountry grants

25 Feb 2019
Another $66 million was approved for interventions on the UQD Register

On 31 January 2019, the Global Fund Board approved three country grants worth $13.4 million. It also approved two multicountry grants valued at $22.5 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). See Tables 1 and 2 for listings of the country and multi-country grants.

1.

Le Conseil d’administration du Fonds mondial approuve une nouvelle tranche de 98 millions de dollars de subventions des allocations 2017/2019

19 Dec 2018
Treize millions de dollars ont également été approuvés pour des subventions multipays
9.

Of the $98 million in country grants approved by Global Fund Board from 2017-2019 allocations, Latin America and Caribbean receive $57 million

11 Dec 2018
Domestic commitments for the nine grants in the region amount to $399 million

This is the second of two articles in this issue on the grants recently approved by the Global Fund Board. In this article, we report on the comments of the Grant Approvals Committee (GAC) on four countries in the Latin American and Caribbean region: Belize, El Salvador, Panama and Paraguay.

1.

Global Fund Board approves another $98 million in country grants from the 2017–2019 allocations

7 Dec 2018
$13 million for multi-country grants also approved
Montenegro one of first transition countries to allocate government financing to key populations

On 12 November 2018,  through electronic voting, the Global Fund Board approved $98.0 million in funding for 14 country grants from 13 countries. Of the 14 grants, four were for TB; three TB/HIV; three HIV; three malaria; and one TB/RSSH.

2.

Plans Are Fine, But Who Has Been Helped?

6 Apr 2004

In the past few years we have heard many announcements - such as today's - about scaling up plans and programs regarding HIV/AIDS treatment. They have come from UNAIDS, WHO, PAHO and the Global Fund, as well as generic and originator drug companies. But after the press coverage dies down, things don't seem to change very much for the people who need these drugs.

Suscribirse a Nicaragua